cafusertib / Jiangsu Hansoh Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cafusertib / Jiangsu Hansoh Pharma
NCT02140606: Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)

Unknown status
1
RoW
Cafusertib Hydrochloride
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Leukemia, Myeloid, Acute
12/15
 
NCT02314884: Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours

Unknown status
1
40
RoW
Cafusertib Hydrochloride
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Neoplasms
12/15
02/16

Download Options